Home › Funds › Relyea Zuckerberg Hanson LLC › ABBV

Relyea Zuckerberg Hanson LLC position in ABBV

ABBVIE INC · Health Care

Relyea Zuckerberg Hanson LLC reported holding 26,046 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 0.57% of its reported portfolio and ranking #40 among its reported holdings. Relyea Zuckerberg Hanson LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)26.05K sh
Reported value held$6.81M
Portfolio Weight0.57%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Relyea Zuckerberg Hanson LLC's ABBV position evolved

Relyea Zuckerberg Hanson LLC first disclosed a stake in ABBV in Q3 2023 at 9,054 shares (US$1.3M). The position peaked in Q2 2026 at 27,498 shares, worth US$6.9M. Across 13 filings, Relyea Zuckerberg Hanson LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 26,046 shares valued at US$6.8M — a reduction of -1,452 shares quarter over quarter.. Notable position changes include a 136% increase in Q4 2024 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.05K $1.35M New
Q4 2023 9.30K $1.44M Add
Q1 2024 9.84K $1.79M Add
Q2 2024 9.97K $1.71M Add
Q3 2024 10.19K $2.01M Add
Q4 2024 24.09K $4.28M Add
Q1 2025 24.31K $5.09M Add
Q2 2025 24.70K $4.59M Add
Q3 2025 24.65K $5.71M Hold
Q4 2025 28.17K $6.44M Add
Q1 2026 27.84K $6.05M Reduce
Q2 2026 27.50K $6.92M Reduce
Q3 2026 26.05K $6.81M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Relyea Zuckerberg Hanson LLC held ABBV?

Relyea Zuckerberg Hanson LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Relyea Zuckerberg Hanson LLC's current position in ABBV?

As of Q3 2026, Relyea Zuckerberg Hanson LLC holds 26.05K shares of ABBV (ABBVIE INC), valued at $6.81M, representing 0.57% of its reported portfolio and ranking #40.

Has Relyea Zuckerberg Hanson LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Relyea Zuckerberg Hanson LLC reduced its position in ABBV. The position peaked in Q2 2026 at 27.50K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.